Roles for CSN5 in control of p53/MDM2 activities

被引:71
|
作者
Zhang, Xiao-Chun [1 ]
Chen, Jian [1 ]
Su, Chun-Hui [1 ,2 ]
Yang, Heng-Yin [1 ]
Lee, Mong-Hong [1 ,2 ,3 ]
机构
[1] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX USA
[3] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX USA
关键词
MDM2; CSN5; ubiquitination; p53; curcumin;
D O I
10.1002/jcb.21504
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 5th subunit of CON signalosome (CSN5, also known as Jab1 or COPS5) is implicated in regulating p53 activity and is overexpressed in various tumors. However, the precise roles of CSN5 in p53 network and tumorigenesis are not well characterized. Here we show that CSN5 is a critical regulator of both p53 and MDM2. We show that curcumin, an important inhibitor of CSN-associated kinases, can downregulate not only CSN5 but also MDM2, which results in p53 stabilization. Importantly, CSN5 interacts with p53. CSN5 expression leads to p53 degradation, facilitating MDM2-mediated p53 ubiquitination, and promoting p53 nuclear export. Additionally, CSN5 expression results in stabilization of MDM2 through reducing MDM2 self-ubiquitination and decelerating turnover rate of MDM2. Significantly, we further show that CSN5 antagonizes the transcriptional activity of p53. These results demonstrate that CSN5 is a pivotal regulator for both p53 and MDM2. Our studies may pave the way for targeting CSN5 for anti-cancer drug development.
引用
收藏
页码:1219 / 1230
页数:12
相关论文
共 50 条
  • [21] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    [J]. NATURE, 1997, 387 (6630) : 299 - 303
  • [22] MDM2: life without p53
    Daujat, S
    Neel, H
    Piette, J
    [J]. TRENDS IN GENETICS, 2001, 17 (08) : 459 - 464
  • [23] A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control
    Li, LM
    Liao, J
    Ruland, J
    Mak, TW
    Cohen, SN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1619 - 1624
  • [24] mdm2/p53与肿瘤
    金永丽
    王靖华
    陈龙邦
    [J]. 临床肿瘤学杂志, 2007, (06) : 469 - 471
  • [25] Mdm2: p53's lifesaver?
    Shmueli, Ayelet
    Oren, Moshe
    [J]. MOLECULAR CELL, 2007, 25 (06) : 794 - 796
  • [26] p53和mdm2基因
    沈行良
    翁启芳
    [J]. 中国热带医学, 2007, (01) : 103 - 105
  • [27] Regulation of p53 stability by Mdm2
    Michael H. G. Kubbutat
    Stephen N. Jones
    Karen H. Vousden
    [J]. Nature, 1997, 387 : 299 - 303
  • [28] MDM2 liberates from p53
    Capoulade, C
    Wiels, J
    [J]. M S-MEDECINE SCIENCES, 1999, 15 (04): : 524 - 527
  • [29] Control of p53 ubiquitination and nuclear export by MDM2 and ARF
    Zhang, YP
    Xiong, Y
    [J]. CELL GROWTH & DIFFERENTIATION, 2001, 12 (04): : 175 - 186
  • [30] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006